Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy

Genetic Testing and Molecular Biomarkers

Volumn 15, Issue 1-2, 2011, Pages 11-15

  Darabi, Maryam ^a   Ani, Mohsen ^a   Panjehpour, Mojtaba ^a   Rabbani, Mohammed ^a   Movahedian, Ahmad ^a,b   Zarean, Elahe ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; ESTROGEN; ESTROGEN RECEPTOR BETA; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; ESTROGEN RECEPTOR BETA; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE;

EID: 79951995784     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0106     Document Type: Article

References (29)

1. Abbas S, Brauch H, Chang-Claude J, et al. (2009) Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int J Cancer 126:2935-2946.
2. Albrecht C, Soumian S, Amey JS, et al. (2004) ABCA1 expression in carotid atherosclerotic plaques. Stroke 35:2801-2806. (Pubitemid 39565174)
3. Allred KF, Smart EJ, Wilson ME (2006) Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors. J Biol Chem 20:1419-1425.
4. Araujo DA, Farias ML, Andrade AT (2002) Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Climacteric 5:286-292.
5. Bortnick AE, Rothblat GH, Stoudt G, et al. (2000) The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275:28634-28640.
6. Christian RC, Liu PY, Harrington S, et al. (2006) Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 91:2713-2720. (Pubitemid 44024642)
7. Domingues-Montanari S, Subirana I, Tomas M, et al. (2008) Association between ESR2 genetic variants and risk of myocardial infarction. Clin Chem 54:1183-1189. (Pubitemid 352009695)
8. Godsland IF (2001) Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 75:898-915.
9. Ichikawa S, Koller DL, Peacock M, et al. (2005) Polymorphisms in the estrogen receptor beta (ESR2) gene are associated with bone mineral density in Caucasian men and women. J Clin Endocrinol Metab 90:5921-5927. (Pubitemid 41606506)
10. Ietta F, Bechi N, Romagnoli R, et al. (2010) 17{beta}-Estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta. Am J Physiol Endocrinol Metab 298:E411-E418.
11. Jiang J, Chang HL, Sugimoto Y, et al. (2005) Effects of age on growth and ERbeta mRNA expression of canine prostatic cells. Anticancer Res 25:4081-4090. (Pubitemid 41665189)
12. Lamon-Fava S, Asztalos BF, Howard TD, et al. (2010) Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women. Clin Endocrinol (Oxf) 72:169-175.
13. Lamon-Fava S, Postfai B, Diffenderfer M, et al. (2006) Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women. Arterioscler Thromb Vasc Biol 26:385-391. (Pubitemid 43732204)
14. Loh FH, Chen LH, Yu SL, et al. (2002) The efficacy of two dosages of a continuous combined hormone replacement regimen. Maturitas 41:123-131. (Pubitemid 34142501)
15. Mansur AP, Nogueira CC, Strunz CM, et al. (2005) Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res 36:511-517. (Pubitemid 41140058)
16. Meyer MR, Barton M (2009) ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis. Cardiovasc Res 83:605-610.
17. Nott SL, Huang Y, Fluharty BR, et al. (2008) Do estrogen receptor beta polymorphisms play a role in the pharmacogenetics of estrogen signaling? Curr Pharmacogenomics Person Med 6:239-259.
18. Ordovas JM (2006) Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 83:443S-446S.
19. Petrella RJ, Merikle E, Jones J (2007) Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis. Clin Ther 29:742-750. (Pubitemid 47018270)
20. Pietzsch J, Julius U, Nitzsche S, et al. (1998) In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes 47:1928-1934.
21. Rifai N, Warnick G (2006) Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis C, Ashwood E, Bruns D (eds) Tietz Textbook of Clinical Chemistry, 26th edition. Elsevier Saunders, Philadelphia, pp 903-968.
22. Rijpkema AHM, van der Sanden AA, Ruijs AHC (1990) Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas 12:259-285. (Pubitemid 20279933)
23. Schimanski S, Wild PJ, Treeck O, et al. (2010) Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res 42:102-109.
24. Silvestri S, Thomsen AB, Gozzini A, et al. (2006) Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause 13:451-461.
25. Srivastava RA (2002) Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem 240:67-73.
26. Sumino H, Ichikawa S, Itoh H, et al. (2003) Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res 60:134-142. (Pubitemid 37034403)
27. Sundarrajan C, Liao WX, Roy AC, et al. (2001) Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders. J Clin Endocrinol Metab 86:135-139. (Pubitemid 32109786)
28. Wagner JD, Clarkson TB, St. Clair RW, et al. (1991) Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest 88:1995-2002.
29. Zhu Y, Bian Z, Lu P, et al. (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295:505-508. (Pubitemid 34101642)